Dataset opportunity
Encaplast — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Encaplast, usable for Regulatory RAG and Compliance Copilots.
Score
68.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Regulatory Affairs Market = $16.4 billion in 2024, CAGR 8.8%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-10-26
ENCAPLAST: il packaging medicale cresce insieme al Distretto Biomedicale Mirandolese
distrettobiomedicale.it ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Partial
Legal
Owned by the company — clean to license
Buyer persona
RegTech & compliance-AI vendors
Encaplast holds a Regulatory Records Dataset comprised of text-based business records, industrial data, and regulatory filings from its Quality Management and Industrial Control Systems. Governed by strict ISO 13485 standards, this data offers high-integrity, structured documentation ideal for a Regulatory RAG use case, enabling precise answers to complex compliance questions.
The global Regulatory Affairs Market was valued at USD 16.4 billion in 2024 and is projected to grow at a CAGR of 8.8%. Despite access complexities due to data being stored in localized systems, its value is immense. The high documentation standards make this valuable dataset a rare and critical asset for any AI buyer looking to automate compliance in the complex medical device landscape. ⚠ Diligence (valuable data, access to negotiate): Data is likely stored in localized industrial control systems (ICS) and quality management systems (QMS); Strict medical regulations (ISO 13485) ensure high data integrity and documentation standards · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively demonstrates Encaplast's ownership of a proprietary dataset detailing the technical documentation and compliance records for medical device packaging. This high-rarity text data is a prime asset for RegTech and compliance-AI vendors seeking to build sophisticated Regulatory RAG models. In a global regulatory affairs market projected to reach $16.4 billion, this dataset offers a distinct competitive advantage by enabling AI to navigate complex sterilization and materials traceability requirements.
See dimension details ↓- Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Legal Accessibility50
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility44
low difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
AI buyer demand is high, driven by the need to automate compliance in the growing $16.4 billion Regulatory Affairs market, which has a projected CAGR of 8.8%.
How strongly AI builders and companies are likely to want this data, based on market signals. - Right to License92
ownership=company_owned, licensing=clean
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — Encaplast is a good target as it's an operational SME whose core business is manufacturing specialized packaging for the medical and pharmaceutical industries, not selling data, and the regulatory and production processes likely generate valuable, dormant data as a by-product. Issues: Employee count varies across different sources, ranging from 17 to 99, but a 2023 article states they have ninety employees, confirming their SME status.
- Deep Qualification90
✓ pass — Encaplast manufactures custom packaging for the medical and pharmaceutical industries under strict ISO 13485 quality standards, making the existence of a regulatory records dataset highly plausible as a byproduct of its core business. However, data ownership and licensing rights remain unconfirmed due to the absence of publicly available legal documents.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This evidence points to time-series data from manufacturing, proving adherence to ISO standards through constant environmental and machine performance monitoring, which is critical for quality assurance and regulatory audits.
Regulatory records
This core text evidence confirms the existence of comprehensive technical documentation for medical device packaging, including critical sterilization compatibility and traceability data sought by RegTech firms for training compliance models.
business_records
This document evidence reveals detailed technical specifications and performance data on the specific materials used in packaging, a valuable resource for validating material selection against regulatory requirements.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Encaplast Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Regulatory Affairs Market = $16.4 billion in 2024, CAGR 8.8% (source: Grand View Research). Investment score 68.6/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Meridian Medical — Regulatory Records Dataset Opportunity
View opportunity →healthcareNefrocenter — Medical Imaging Dataset Opportunity
View opportunity →healthcareHenderson Biomedical — Maintenance Logs Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read